OptimizeRx Corporation
OPRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $88,904 | $245,056 | $298,771 | $1,070,032 |
| - Cash | $13,380 | $13,852 | $18,209 | $84,682 |
| + Debt | $33,193 | $36,824 | $234 | $328 |
| Enterprise Value | $108,717 | $268,027 | $280,797 | $985,678 |
| Revenue | $92,127 | $71,522 | $62,450 | $61,293 |
| % Growth | 28.8% | 14.5% | 1.9% | – |
| Gross Profit | $59,378 | $42,900 | $38,967 | $35,638 |
| % Margin | 64.5% | 60% | 62.4% | 58.1% |
| EBITDA | -$8,896 | -$21,308 | -$9,416 | $2,326 |
| % Margin | -9.7% | -29.8% | -15.1% | 3.8% |
| Net Income | -$20,110 | -$17,566 | -$11,438 | $378 |
| % Margin | -21.8% | -24.6% | -18.3% | 0.6% |
| EPS Diluted | -1.1 | -1.03 | -0.64 | 0.021 |
| % Growth | -6.8% | -60.9% | -3,090.7% | – |
| Operating Cash Flow | $4,889 | -$7,240 | $10,654 | $726 |
| Capital Expenditures | -$112 | -$871 | -$245 | -$486 |
| Free Cash Flow | $4,777 | -$8,111 | $10,410 | $240 |